You have 9 free searches left this month | for more free features.

shr-1316

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial in Perth (SHR-1316)

Completed
  • Advanced Solid Tumors
  • SHR-1316
  • Perth, West Australia, Australia
    Linear Clinical Research
Jul 11, 2022

Tumor Trial (SHR-1316)

Not yet recruiting
  • Tumor
  • SHR-1316
  • (no location specified)
Jul 16, 2021

Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Metastatic Cancer
  • SHR-1316
  • +4 more
  • (no location specified)
Jan 11, 2022

Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)

Not yet recruiting
  • Breast Neoplasm
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022

Limited-stage Small Cell Lung Cancer, LS-SCLC Trial (SHR-1316)

Not yet recruiting
  • Limited-stage Small Cell Lung Cancer, LS-SCLC
  • SHR-1316
  • (no location specified)
Nov 27, 2020

Small Cell Lung Cancer Trial in Chengdu (Fluzoparib, temozolomide, SHR-1316)

Unknown status
  • Small Cell Lung Cancer
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jun 19, 2020

Breast Cancer Trial (Pyrotinib, Temozolomide Injection, SHR-1316)

Unknown status
  • Breast Cancer
  • (no location specified)
Mar 9, 2020

Advanced Esophageal Squamous Cell Cancer Trial in Beijing (Irinotecan liposome, SHR-1316, Fluorouracil)

Unknown status
  • Advanced Esophageal Squamous Cell Cancer
  • Irinotecan liposome
  • +2 more
  • Beijing, Beijing, China
    Cancer Institute and Hospital,Chinese Academy of Medical Science
Nov 5, 2018

Tumor Trial in Shanghai (SHR-1316)

Unknown status
  • Tumor
  • SHR-1316
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2018